Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Case Report
Robotic-Assisted Revascularization of Femoropopliteal Restenosis After Atherectomy in a Patient With Challenging Vascular Anatomy
09/13/2021
The author reports use of the CorPath GRX Robotic System for revascularization of right leg critical limb ischemia using a left transradial approach.
The author reports use of the CorPath GRX Robotic System for revascularization of right leg critical limb ischemia using a left transradial approach.
The author reports use of the...
09/13/2021
Vascular Disease Management
Interview
DISRUPT PAD III Trial Summary
07/19/2021
A brief trial summary and interviews with William A. Gray, MD, and Christopher J. White, MD, regarding the DISRUPT PAD trial.
A brief trial summary and interviews with William A. Gray, MD, and Christopher J. White, MD, regarding the DISRUPT PAD trial.
A brief trial summary and...
07/19/2021
Vascular Disease Management
Editor's Corner
The Increasing Use of Transradial Approach for Peripheral Interventions
06/11/2021
Craig Walker, MD, discusses Ansaarie et al’s article, “A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Minimal Arterial Access Lower-Extremity Intervention Via Peripheral Orbital Atherectomy.”
Craig Walker, MD, discusses Ansaarie et al’s article, “A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Minimal Arterial Access Lower-Extremity Intervention Via Peripheral Orbital Atherectomy.”
Craig Walker, MD, discusses...
06/11/2021
Vascular Disease Management
Original Contribution
A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Minimal Arterial Access Lower-Extremity Intervention Via Peripheral Orbital Atherectomy
06/11/2021
The primary objective of this study was to evaluate the clinical success of peripheral orbital atherectomy procedures with transradial access.
The primary objective of this study was to evaluate the clinical success of peripheral orbital atherectomy procedures with transradial access.
The primary objective of this...
06/11/2021
Vascular Disease Management
Podcasts
Treating PAD With Next-Generation Drug-Eluting Technologies
04/27/2021
In this episode of VDM Voices, we discuss next-generation DE technologies, Ranger Drug-Coated Balloon and Eluvia Drug-Eluting Stent, and the impact for clinicians and patients fighting PAD. Our guest is Dr. Robert Lookstein, a professor of...
In this episode of VDM Voices, we discuss next-generation DE technologies, Ranger Drug-Coated Balloon and Eluvia Drug-Eluting Stent, and the impact for clinicians and patients fighting PAD. Our guest is Dr. Robert Lookstein, a professor of...
In this episode of VDM Voices,...
04/27/2021
Vascular Disease Management
Original Research
Correlation Between Ankle Brachial Index and SYNTAX Score to Predict Severity of Coronary Artery Disease
02/26/2021
Atherosclerosis is a disease of the large and medium-sized arteries resulting in luminal stenosis, resulting from accumulation of lipids and fibrosis between the arterial intima and its media.
Atherosclerosis is a disease of the large and medium-sized arteries resulting in luminal stenosis, resulting from accumulation of lipids and fibrosis between the arterial intima and its media.
Atherosclerosis is a disease of...
02/26/2021
Vascular Disease Management
Case Report
Transradial Carotid Artery Stenting Complicated With Neck Hematoma: Conservative Is a Valid Option!
02/16/2021
Carotid artery stenting—when performed by an experienced operator using an embolic protection device—provides a good alternative for carotid endarterectomy in high-risk patients.
Carotid artery stenting—when performed by an experienced operator using an embolic protection device—provides a good alternative for carotid endarterectomy in high-risk patients.
Carotid artery stenting—when...
02/16/2021
Vascular Disease Management
Case Report
A Curious Case of Hypercoagulability
01/13/2021
Peripheral artery disease and coronary artery disease are the onset of arterial occlusions leading to symptoms associated with claudication and angina, respectively.
Peripheral artery disease and coronary artery disease are the onset of arterial occlusions leading to symptoms associated with claudication and angina, respectively.
Peripheral artery disease and...
01/13/2021
Vascular Disease Management
Case Report
Micropuncture Access of Femoral Artery: Micro-Wires Leading to Macro-Complications
12/17/2020
A 76-year-old female who developed sudden and severe left calf and foot pain after recent travel was found to have subtotal occlusion of the left popliteal artery and critical limb ischemia. Vascular access in the right CFA with a...
A 76-year-old female who developed sudden and severe left calf and foot pain after recent travel was found to have subtotal occlusion of the left popliteal artery and critical limb ischemia. Vascular access in the right CFA with a...
A 76-year-old female who...
12/17/2020
Vascular Disease Management
Original Research
Effect of Nitrate Administration on Peak Systolic Velocity in Peripheral Arterial Disease Patients at Sardjito General Hospital in Yogyakarta
11/18/2020
Little is known about the role of nitrate or nitric oxide administration to improve symptomatic PAD patients. The purpose of this study is to observe the effect of nitrate administration on peak systolic velocity ratios in PAD patients.
Little is known about the role of nitrate or nitric oxide administration to improve symptomatic PAD patients. The purpose of this study is to observe the effect of nitrate administration on peak systolic velocity ratios in PAD patients.
Little is known about the role...
11/18/2020
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement